Agoracom: Small Cap Investment - Zenith Epigenetics - Re: AGM

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: AGM - High Level Summary

posted on Jan 08, 2016 07:18AM

A few tidbits from my emailing with Sarah yesterday:

There will be no webcast next week for either company (Zenith or RVX) at Biotech Showcase. However, there will be a RVX webcast in Q1 2016.

Zenith PPT presentation will be posted on the website after its presented and will have the same slides presented at the AGM.

Everything passed at the Zenith AGM. Since Zenith is not listed, a press release is not required.